Cargando…
Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624201/ https://www.ncbi.nlm.nih.gov/pubmed/37921671 http://dx.doi.org/10.18632/oncotarget.28533 |
| _version_ | 1785130876034613248 |
|---|---|
| author | Bayraktar, Recep Pichler, Martin Kanlikilicer, Pinar Ivan, Cristina Bayraktar, Emine Kahraman, Nermin Aslan, Burcu Oguztuzun, Serpil Ulasli, Mustafa Arslan, Ahmet Calin, George Lopez-Berestein, Gabriel Ozpolat, Bulent |
| author_facet | Bayraktar, Recep Pichler, Martin Kanlikilicer, Pinar Ivan, Cristina Bayraktar, Emine Kahraman, Nermin Aslan, Burcu Oguztuzun, Serpil Ulasli, Mustafa Arslan, Ahmet Calin, George Lopez-Berestein, Gabriel Ozpolat, Bulent |
| author_sort | Bayraktar, Recep |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10624201 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106242012023-11-04 Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase Bayraktar, Recep Pichler, Martin Kanlikilicer, Pinar Ivan, Cristina Bayraktar, Emine Kahraman, Nermin Aslan, Burcu Oguztuzun, Serpil Ulasli, Mustafa Arslan, Ahmet Calin, George Lopez-Berestein, Gabriel Ozpolat, Bulent Oncotarget Correction Impact Journals LLC 2023-10-31 /pmc/articles/PMC10624201/ /pubmed/37921671 http://dx.doi.org/10.18632/oncotarget.28533 Text en Copyright: © 2023 Bayraktar et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Bayraktar, Recep Pichler, Martin Kanlikilicer, Pinar Ivan, Cristina Bayraktar, Emine Kahraman, Nermin Aslan, Burcu Oguztuzun, Serpil Ulasli, Mustafa Arslan, Ahmet Calin, George Lopez-Berestein, Gabriel Ozpolat, Bulent Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase |
| title | Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase |
| title_full | Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase |
| title_fullStr | Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase |
| title_full_unstemmed | Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase |
| title_short | Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase |
| title_sort | correction: microrna 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624201/ https://www.ncbi.nlm.nih.gov/pubmed/37921671 http://dx.doi.org/10.18632/oncotarget.28533 |
| work_keys_str_mv | AT bayraktarrecep correctionmicrorna603actsasatumorsuppressorandinhibitstriplenegativebreastcancertumorigenesisbytargetingelongationfactor2kinase AT pichlermartin correctionmicrorna603actsasatumorsuppressorandinhibitstriplenegativebreastcancertumorigenesisbytargetingelongationfactor2kinase AT kanlikilicerpinar correctionmicrorna603actsasatumorsuppressorandinhibitstriplenegativebreastcancertumorigenesisbytargetingelongationfactor2kinase AT ivancristina correctionmicrorna603actsasatumorsuppressorandinhibitstriplenegativebreastcancertumorigenesisbytargetingelongationfactor2kinase AT bayraktaremine correctionmicrorna603actsasatumorsuppressorandinhibitstriplenegativebreastcancertumorigenesisbytargetingelongationfactor2kinase AT kahramannermin correctionmicrorna603actsasatumorsuppressorandinhibitstriplenegativebreastcancertumorigenesisbytargetingelongationfactor2kinase AT aslanburcu correctionmicrorna603actsasatumorsuppressorandinhibitstriplenegativebreastcancertumorigenesisbytargetingelongationfactor2kinase AT oguztuzunserpil correctionmicrorna603actsasatumorsuppressorandinhibitstriplenegativebreastcancertumorigenesisbytargetingelongationfactor2kinase AT ulaslimustafa correctionmicrorna603actsasatumorsuppressorandinhibitstriplenegativebreastcancertumorigenesisbytargetingelongationfactor2kinase AT arslanahmet correctionmicrorna603actsasatumorsuppressorandinhibitstriplenegativebreastcancertumorigenesisbytargetingelongationfactor2kinase AT calingeorge correctionmicrorna603actsasatumorsuppressorandinhibitstriplenegativebreastcancertumorigenesisbytargetingelongationfactor2kinase AT lopezberesteingabriel correctionmicrorna603actsasatumorsuppressorandinhibitstriplenegativebreastcancertumorigenesisbytargetingelongationfactor2kinase AT ozpolatbulent correctionmicrorna603actsasatumorsuppressorandinhibitstriplenegativebreastcancertumorigenesisbytargetingelongationfactor2kinase |